These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 5231829)

  • 21. A comparison of two regimens of streptomycin plus PAS in the retreatment of pulmonary tuberculosis.
    Tubercle; 1968 Mar; 49(1):70-8. PubMed ID: 5660586
    [No Abstract]   [Full Text] [Related]  

  • 22. [A case of pancythopenia following combined therapy with streptomycin and Napashin].
    Oleniacz W; Dzierzkowa-Bordej W
    Gruzlica; 1967 Jan; 35(1):71. PubMed ID: 6044452
    [No Abstract]   [Full Text] [Related]  

  • 23. The need for new antituberculous drugs.
    Dahlström G
    Scand J Respir Dis Suppl; 1969; 69():11-3. PubMed ID: 4906370
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of some antituberculous drugs upon the upper gastrointestinal tract: an experiment with para-aminosalicylic acid, isoniazid, and streptomycin.
    Varis K; Koskinen R; Jussila J; Rytömaa T; Tarpila S; Launiala K
    Scand J Gastroenterol; 1971; 6(7):589-95. PubMed ID: 5128066
    [No Abstract]   [Full Text] [Related]  

  • 25. [Comparative study (tolerance and effectiveness) of classic antituberculous therapy (P.A.S.-streptomycin-isoniazid) and a new combination (prothionamide-streptomycin-isoniazid)].
    Charpin J; Taranger J; Boutin C; Girbal JP
    Mars Med; 1969; 106(11):895-7. PubMed ID: 5407168
    [No Abstract]   [Full Text] [Related]  

  • 26. Incidence of drug hypersensitivity in the chemotherapy of tuberculosis.
    Govindaraj M; Grant LJ
    Br J Dis Chest; 1968 Jan; 62(1):27-31. PubMed ID: 5656836
    [No Abstract]   [Full Text] [Related]  

  • 27. [Side effects of antibacterial drugs in the clinical course of pulmonary tuberculosis].
    Czkwianianc M; Markiewicz I
    Przegl Lek; 1969 Jun; 25(6):479-81. PubMed ID: 5805095
    [No Abstract]   [Full Text] [Related]  

  • 28. Incidence of drug intolerance to antituberculosis chemotherapy.
    Neff TA; Coan BJ
    Dis Chest; 1969 Jul; 56(1):10-2. PubMed ID: 5789831
    [No Abstract]   [Full Text] [Related]  

  • 29. [Some functional shifts occurring in the cardiovascular system, following a long-term antibacterial treatment].
    Reĭnval'd LA
    Probl Tuberk; 1970; 48(5):41-4. PubMed ID: 5449568
    [No Abstract]   [Full Text] [Related]  

  • 30. Tolerance to ethionamid and PAS in original treatment of tuberculous patients.
    Verbist L; Prignot J; Cosemans J; Gyselen A
    Scand J Respir Dis; 1966; 47(4):225-35. PubMed ID: 5182290
    [No Abstract]   [Full Text] [Related]  

  • 31. [Liver function and INH and PAS metabolism in tuberculous adolescents with side reactions to chemotherapy].
    Tytor IaN; Koropetskiĭ VI
    Vrach Delo; 1977 Jun; (6):61-4. PubMed ID: 883281
    [No Abstract]   [Full Text] [Related]  

  • 32. [Desensitization therapy for allergic reactions of antituberculous drugs--evaluation of desensitization therapy according to the guideline of the Japanese Society for Tuberculosis].
    Kobashi Y; Okimoto N; Matsushima T; Abe T; Nishimura K; Shishido S; Kawahara S; Shigeto E; Takeyama H; Kuraoka T
    Kekkaku; 2000 Dec; 75(12):699-704. PubMed ID: 11201137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Results of one-year chemotherapy with isoniazid (INH), streptomycin (SM) and ethionamide (ETA) in previously untreated patients with cavernous pulmonary tuberculosis.
    Zajaczkowska J; Krychniak W; Krakówka P; Buraczewska M
    Pol Med J; 1966; 5(2):339-44. PubMed ID: 5915720
    [No Abstract]   [Full Text] [Related]  

  • 34. [Drug intolerance and depressive states in tubercular patients].
    Scherding JP; Suerinck E
    Rev Tuberc Pneumol (Paris); 1967; 31(1):55-60. PubMed ID: 6037247
    [No Abstract]   [Full Text] [Related]  

  • 35. [Methemoglobinemia and hemolytic anemia caused by para-aminosalicylic acid (PAS) infusion therapy].
    Mastella G; Orlandi P; Garofalo E; Lorenzini E
    Fracastoro; 1966; 59(6):702-16. PubMed ID: 5301822
    [No Abstract]   [Full Text] [Related]  

  • 36. [Electroencephalographic supervision of pulmonary tuberculous patients submitted to combined isoniazid and prothionamide therapy (apropos of 50 cases)].
    Fabre C; Rullière R; Milochevitch R; Geier S; Letonturier P
    Rev Tuberc Pneumol (Paris); 1967; 31(6):829-42. PubMed ID: 5622518
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effectiveness of prolonged antibacterial therapy in newly detected patients with active pulmonary tuberculosis].
    Kuropatkin IF; Chuprova KP
    Probl Tuberk; 1967; 45(9):32-5. PubMed ID: 5606475
    [No Abstract]   [Full Text] [Related]  

  • 38. [Comparative study of therapeutic effect and side actions of 1314 TH and 1321 TH in the initial therapy of tuberculosis].
    Sunahara S; Nagasawa S
    Saishin Igaku; 1969 Apr; 24(4):922-7. PubMed ID: 5807960
    [No Abstract]   [Full Text] [Related]  

  • 39. [Preliminary findings and considerations on primary resistance to SM, INI, and PAS in the Provincial Antitubercular Association of Naples].
    Romano S; Grella G
    Rass Int Clin Ter; 1966 Dec; 46(23):1311-6. PubMed ID: 5997869
    [No Abstract]   [Full Text] [Related]  

  • 40. [Diabetes mellitus and pulmonary tuberculosis].
    Alimpić D; Popović S
    Z Erkr Atmungsorgane Folia Bronchol; 1970; 132(2):187-94. PubMed ID: 5203360
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.